offline
Celgene's stock tumbles after Bristol-Myers shareholders oppose the buyout deal
Shares of Celgene Corp. CELG, tumbled 8.0% in afternoon trade Thursday, after Bristol-Myers Squibb Co. BMY, +1.37% shareholder Starboard Value L.P. said it plans to vote all of its shares against Bristol-Myers' proposed acquisition of Celgene.
...
https://www.marketwatch.com/story/celgen...2019-02-28
![[Bild: CELGc1dl1735.png]](https://finviz.com/publish/022819/CELGc1dl1735.png)
Shares of Celgene Corp. CELG, tumbled 8.0% in afternoon trade Thursday, after Bristol-Myers Squibb Co. BMY, +1.37% shareholder Starboard Value L.P. said it plans to vote all of its shares against Bristol-Myers' proposed acquisition of Celgene.
...
https://www.marketwatch.com/story/celgen...2019-02-28
__________________
